Paroxetine Quantitative, Serum or Plasma
Also known as: PAROXE SP
Use
Paroxetine Quantitative testing is crucial for monitoring therapeutic drug levels and ensuring dosage accuracy. This test provides quantitative analysis of Paroxetine levels in serum or plasma, aiding in the management of patients on this antidepressant medication. Due to the inter-individual variability in paroxetine plasma levels, accurate measurement is essential for optimizing therapeutic efficacy and minimizing side effects.
Special Instructions
This test is performed by a non-ARUP laboratory, and separate specimens must be submitted when multiple tests are ordered. The test requires specific specimen handling and transfer protocols to ensure accurate results.
Limitations
The test was developed and its performance characteristics determined by the testing laboratory, NMS Labs, and has not been cleared or approved by the US Food and Drug Administration. There is a significant inter-individual variability in paroxetine levels, which can impact the interpretation of results.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 9699-0
Result Turnaround Time
4-7 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.4 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube.
Causes for Rejection
Separator tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 2 weeks |
| Refrigerated | 1 month |
| Frozen | 6 months |